Table 1 Clinicopathological data for MSI+ CRCs analyzed in-lab
Clinicopathological parameters | Norwegian series I (n = 78) | Norwegian series II (n = 31) | VICTOR (n = 81) | |
|---|---|---|---|---|
All patients | Exome sequenced (n = 33) | |||
Patient age at diagnosis (years) | ||||
Mean | 75 | 74 | 66 | 65 |
Min | 37 | 37 | 26 | 38 |
Max | 93 | 93 | 92 | 89 |
Patient gender | ||||
Female | 55 | 23 | 18 | 45 |
Male | 23 | 10 | 13 | 36 |
Tumor localization | ||||
Right | 68 | 31 | 20 | 66 |
Left | 6 | 1 | 7 | 13 |
Rectum | 4 | 1 | 4 | - |
Unknown | - | - | - | 2 |
Tumor stage | ||||
I | 16 | 1 | 3 | - |
II | 42 | 23 | 17 | 54 |
III | 15 | 9 | 8 | 27 |
IV | 5 | - | 3 | - |
5-year survival rates | ||||
Overall | 71% | 85% | 83% | 82% |
Relapse-free | 70% | 82% | 72% | NA |